Acceleron Pharma (XLRN) Jumps: Stock Up 13.2% - Tale of the Tape - Alkermes (NASDAQ:ALKS)

Acceleron Pharma, Inc. XLRN was a big mover last session, as its shares rose over 13% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since March 3, as the stock is now down nearly 27%.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Acceleron Pharma currently has a Zacks Rank #3 (Sell) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include ANI Pharmaceuticals, Inc. ANIP, Alkermes plc ALKS and Alexion Pharmaceuticals, Inc. ALXN. All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALKERMES INC ALKS: Free Stock Analysis Report

ALEXION PHARMA ALXN: Free Stock Analysis Report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

ACCELERON PHARM XLRN: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs